PDLI Net Income Growth
Pdl Biopharma Inc · Net Income Growth
PDLI Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-18166.40%period ending
PDLI TTM Net Income YoY % (-68.46% → -18166.40%)
Year-over-year change
High-resolution chart · PNG
PDLI net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -18,166.4021% | |
| -450.068% | |
| -70.6057% | |
| -2.2539% | |
| 101.2038% | |
| 165.2057% | |
| -160.6808% | |
| -162.1763% | |
| -180.437% | |
| -194.9124% | |
| 602.6003% | |
| 74.1156% | |
| -55.2614% | |
| -69.0305% | |
| -95.0819% | |
| -80.8873% | |
| -39.2548% | |
| -28.119% | |
| -8.8885% | |
| 3.2742% | |
| -12.4817% | |
| 13.3968% | |
| 17.58% | |
| 21.8176% | |
| 29.828% | |
| 15.114% | |
| 26.2211% | |
| 24.9734% | |
| 25.6671% | |
| 23.4971% | |
| 15.3455% | |
| 6.1588% | |
| 47.9575% | |
| 52.4213% | |
| 76.6366% | |
| 117.0244% | |
| -6.1473% | |
| -13.7985% | |
| -38.0439% | |
| -51.5586% | |
| -28.1775% | |
| -28.3916% | |
| 6.2551% | |
| 177.3334% | |
| 1,557.8108% | |
| 527.9885% | |
| 349.1666% | |
| 526.2731% | |
| 113.4953% | |
| 45.8836% | |
| 41.1588% | |
| 87.6611% | |
| -12.4003% | |
| 19.2643% | |
| -5.0353% | |
| 21.946% | |
| 43.203% | |
| 2.2817% | |
| 12.5331% | |
| -212.8735% | |
| -26.6562% | |
| 1.1301% | |
| 15.0065% | |
| 58.9873% | |
| -71.9952% | |
| -116.4878% | |
| -1,084.8201% | |
| -792.0223% | |
| -439.5606% | |
| -829.938% | |
| -487.9696% | |
| -649.7922% | |
| -251.2714% | |
| -225.4215% | |
| -132.3141% | |
| 309.119% | |
| 252.7105% | |
| 4,928.2609% | |
| 185.2949% | |
| 106.2816% | |
| 45.8125% | |
| 101.011% | |
| -4.5205% | |
| -9.5745% | |
| 52.7094% | |
| 58.4475% | |
| 69.3277% | |
| 60.6695% | |
| -111.4583% | |
| -68.4615% |